ResearcherUniversity College LondonActive in the last 2 years
Dimitrios E. Magouliotis
Matched on ORCID iD 0000-0001-5417-6392; OpenAlex author ID A5050964695. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper
Papers 10
- Validation of Perioperative Troponin Levels for Predicting Postoperative Mortality and Long-Term Survival in Patients Undergoing Surgery for Hepatobiliary and … Co-author DOI 10.3390/jcdd11040130↗
- Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with Pancreatic Cancer Undergoing Surgery. Co-author DOI 10.3390/jcm12062327↗
- A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for patients with locally advanced pancreatic ca… First author DOI 10.1007/s00261-021-03334-y↗
- Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/invivo.12809↗
- Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Co-author DOI 10.3390/medicina58111663↗
- Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. Co-author DOI 10.1016/j.bjane.2020.10.018↗
- The surgical challenge of oligometastatic pancreatic cancer: A systemic review of the literature. First author PMID 34761577↗
- In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Panel of Seven Prognostic Markers in Patient… Co-author DOI 10.2174/1389202921666200316115631↗
- Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic duct… Co-author DOI 10.1016/j.pan.2019.02.006↗
- Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer? Co-author DOI 10.1016/j.jprot.2018.01.012↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dimitris Zacharoulis · 7 shared papers, 2019–2023 · strength 1.10
- Paper Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with… DOI 10.3390/jcm12062327↗
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. DOI 10.1016/j.bjane.2020.10.018↗
- Konstantinos S. Dimas · 5 shared papers, 2018–2022 · strength 0.64
- Paper Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma. DOI 10.21873/invivo.12809↗
- Paper Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. DOI 10.3390/medicina58111663↗
- Paper In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Pane… DOI 10.2174/1389202921666200316115631↗
- Athina A. Samara · 3 shared papers, 2022–2024 · strength 0.54
- Paper Validation of Perioperative Troponin Levels for Predicting Postoperative Mortality and Long-Term Survival in Patients U… DOI 10.3390/jcdd11040130↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with… DOI 10.3390/jcm12062327↗
- Paper Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. DOI 10.3390/medicina58111663↗
- Maria P. Fergadi · 3 shared papers, 2021–2023 · strength 0.52
- Paper Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for Predicting Postoperative Mortality in Patients with… DOI 10.3390/jcm12062327↗
- Paper Validation of the Surgical Outcome Risk Tool (SORT) in patients with pancreatic cancer undergoing surgery. DOI 10.1016/j.bjane.2020.10.018↗
- Paper A meta-analysis evaluating the role of high-intensity focused ultrasound (HIFU) as a fourth treatment modality for pati… DOI 10.1007/s00261-021-03334-y↗
- Dimitris Zacharoulis · 3 shared papers, 2018–2024 · strength 0.41
- Paper Validation of Perioperative Troponin Levels for Predicting Postoperative Mortality and Long-Term Survival in Patients U… DOI 10.3390/jcdd11040130↗
- Paper In Silico Transcriptomic Analysis of the Chloride Intracellular Channels (CLIC) Interactome Identifies a Molecular Pane… DOI 10.2174/1389202921666200316115631↗
- Paper Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devas… DOI 10.1016/j.jprot.2018.01.012↗
- Anna P. Karamolegkou · 2 shared papers, 2022–2023 · strength 0.34
- Dimitrios Symeonidis · 1 shared paper, 2021 · strength 0.17
- Gregory Christodoulidis · 1 shared paper, 2021 · strength 0.15
- Evangelia Sereti · 1 shared paper, 2018 · strength 0.08
- Konstantinos Vellios Kamposioras · 1 shared paper, 2018 · strength 0.08
- Engı̇n Ulukaya · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.